Cargando…

Feasibility and stability of left bundle branch pacing in patients after prosthetic valve implantation

BACKGROUND: Left bundle branch pacing (LBBP) has emerged as a promising pacing modality for preventing pacing induced cardiomyopathy in patients complicated with conduction abnormalities (CAs) after prosthetic valve (PV) implantation. OBJECTIVE: The present study aimed to evaluate the safety and fea...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jincun, Li, Linlin, Xiao, Guosheng, Huang, Xinyi, Li, Qiang, Wang, Yan, Cai, Binni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533988/
https://www.ncbi.nlm.nih.gov/pubmed/32609400
http://dx.doi.org/10.1002/clc.23413
Descripción
Sumario:BACKGROUND: Left bundle branch pacing (LBBP) has emerged as a promising pacing modality for preventing pacing induced cardiomyopathy in patients complicated with conduction abnormalities (CAs) after prosthetic valve (PV) implantation. OBJECTIVE: The present study aimed to evaluate the safety and feasibility of LBBP in this patient population. METHODS: LBBP was attempted in 20 patients complicated with atrioventricular block after PV implantation. Surface, intracardiac electrical measurements, and echocardiographic data were documented. Lead parameters and complications were routinely tracked at implantation and each follow‐up visit. RESULTS: LBBP was successful in 90% (18/20) participants. The paced QRS duration and the stimulus to left ventricular activation time were 106.8 ± 6.8 ms and 65.5 ± 5.4 ms, respectively. Left bundle branch (LBB) potential was recorded in 61.1% (11/18) patients who succeeded in LBBP. During the procedure, the mean unipolar myocardium capture threshold was 0.51 ± 0.15 V@0.4 ms while the unipolar bundle capture threshold was 0.84 ± 0.51 V@0.4 ms. The mean fluoroscopic exposure time and the radiation dose were 13.0 ± 9.2 min and 81.7 ± 8.3 mGy, respectively. The average follow‐up period was 10.4 ± 5.9 months (range 3‐23 months). Pacing parameters remained stable and no significant lead‐related complications occurred during the whole observation period. CONCLUSIONS: LBBP was safe and feasible in patients with PVs. Acceptable and stable pacing parameters could be expected during the procedure and the follow‐ups.